<img height="1" width="1" alt="facebook pixel" style="display:none" src="https://www.facebook.com/tr?id=347601569260523&amp;ev=PageView&amp;noscript=1">

Technology has a critical role to play in helping patients, and the clinicians and institutions they trust, make every moment matter in the fight against cancer.

This blog represents an ideas exchange on how exciting new innovation could be applied to assist at each step in the patient pathway.

Sign up to receive updates about new posts on this collaborative blog.
future-blog-2-no-shadow
FDA's Response to the Proposed Exemption of Section 510(k) Requirements
By Richard Morroney, RAC, CQA On April 21, 2021

FDA's Response to the Proposed Exemption of Section 510(k) Requirements

On January 15, 2021, the Department of Health and Human Services (HHS) issued a Notice in the Federal Register that, among other...


( read )

Topics: digital pathology, regulation, FDA,

New FDA Pronouncement Paves the Way for Digital Pathology's Rise
By Richard Morroney, RAC, CQA On January 25, 2021

New FDA Pronouncement Paves the Way for Digital Pathology's Rise

When COVID-19 surprised us in early 2020, digital pathology providers had few FDA-cleared options to leverage their solutions,...


( read )

Topics: digital pathology, regulation, FDA,

The Over-Regulation of Digital Pathology Systems
By Richard Morroney, RAC, CQA On June 5, 2020

The Over-Regulation of Digital Pathology Systems

Why does it take a pandemic to reset overly burdensome medical device regulations?Whole slide imaging (WSI) system technology is...


( read )

Topics: digital pathology, regulation, FDA,

VIEW MORE

Fireside Chat: Scalable Insights, From Diagnosis to Survival

Originally streamed on October 5th, 2021; This virtual event brought together three key members of the Inspirata team, to discuss how Dynamyx, E-Path, and Trial Navigator can help healthcare institutions to achieve insights that scale across the entire oncology organization.

 

Watch On-Demand